12:00 AM, 5th Dec 2024
The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned Divi's Labs shares fall nearly 3% as US court says Novartis cannot block generic of best-selling heart drug. The response from the Company is attached.